RxDoctor Payments Data

Olga Bachilo

Plastic and Reconstructive Surgery · Bellaire, TXNPI 1538454731

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,543 of the $15,543 with a category attached, or 67.8%. 20 manufacturers reported payments, led by AbbVie at 45.4% of the total. Reporting peaked in 2021 at $6,545 and has fallen 80.5% since, to $1,274 in 2025.

$15,543in general payments, 2019–2025

Across 153 payments — averaging $101.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Merz North America, Inc.$1K
  • Galderma Laboratories, L.p.$1K
  • Sientra, Inc.$1K
  • Mentor Worldwide LLC$885
  • Davol Inc.$690
  • plus $3K from 14 others

What the payments were for

  • Speaking & faculty fees$5,00032%
  • Food & beverage$10,54368%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,543 in reported general payments places this provider in the 85th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas

Other plastic and reconstructive surgery in Bellaire

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →